Loading...

Biogen Inc.

IDP.DE•XETRA
Healthcare
Drug Manufacturers - General
€151.64
€-1.74(-1.13%)
German Market opens in 7h 54m

Biogen Inc. (IDP.DE) Stock Overview

Explore Biogen Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap22.3B
P/E Ratio20.30
EPS (TTM)$7.52
ROE0.07%
Fundamental Analysis

AI Price Forecasts

1 Month$130.52
3 Months$183.84
1 Year Target$96.74

IDP.DE Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Biogen Inc. (IDP.DE) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 43.74, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $96.74.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 20.30 and a market capitalization of 22.3B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-1.13%
5-Day Change
1.40%
1-Month Change
-5.76%
3-Month Change
4.47%
6-Month Change
23.03%
Year-to-Date (YTD) Change
0.89%
1-Year Change
45.46%
3-Year Change
-43.04%
5-Year Change
-32.98%
All-Time (Max) Change
229.44%

Contact Information

https://www.biogen.com
617 679 2000
225 Binney Street, Cambridge, MA, 02142

Company Facts

76,050 Employees
IPO DateJan 3, 2000
CountryUS
Actively Trading

Frequently Asked Questions